{"id":1253,"date":"2023-06-02T09:00:00","date_gmt":"2023-06-02T09:00:00","guid":{"rendered":"https:\/\/lee-pharm.com\/provincial-center-for-adr-monitoring-visited-zhaoke-hefei-on-assessment-of-pharmacovigilance-system\/"},"modified":"2026-09-24T09:22:36","modified_gmt":"2026-09-24T09:22:36","slug":"provincial-center-for-adr-monitoring-visited-zhaoke-hefei-on-assessment-of-pharmacovigilance-system","status":"publish","type":"post","link":"https:\/\/lee-pharm.com\/en\/provincial-center-for-adr-monitoring-visited-zhaoke-hefei-on-assessment-of-pharmacovigilance-system\/","title":{"rendered":"Provincial Center for ADR Monitoring visited Zhaoke-Hefei on assessment of pharmacovigilance system"},"content":{"rendered":"<p>May 23, 2023, the Provincial Center for ADR Monitoring and the Provincial Medical Products Administration visited Zhaoke Pharmaceutical (Hefei) Company Limited (&#8220;Zhaoke Hefei&#8221;), a subsidiary of Lee\u2019s Pharmaceutical Holdings Limited (\u201cLee\u2019s Pharm\u201d or \u201cthe Group\u201d, HKEx:00950), to conduct on-site assessment. More than 10 pharmaceutical enterprises in Hefei were also invited, including representative enterprises which manufacture drugs selected for VBP, biological medicinal products and Chinese medicine preparations.<\/p>\n<p class=\"lpns-download-wrap\"><a class=\"lpns-download\" href=\"https:\/\/www.leespharm.com\/wp-content\/uploads\/2023\/06\/2023.06.02-Provincial-Center-for-ADR-Monitoring-visited-Zhaoke-Hefei-on-assessment-of-pharmacovigilance-system.pdf\" target=\"_blank\" rel=\"noopener\">\u0e14\u0e32\u0e27\u0e19\u0e4c\u0e42\u0e2b\u0e25\u0e14\u0e02\u0e48\u0e32\u0e27\u0e09\u0e1a\u0e31\u0e1a\u0e40\u0e15\u0e47\u0e21 (PDF)<\/a><\/p>\n<p><em>\u0e17\u0e35\u0e48\u0e21\u0e32: <a href=\"https:\/\/www.leespharm.com\/media\/?filter=Recent\" target=\"_blank\" rel=\"noopener\">Lee&#8217;s Pharmaceutical Holdings \u2013 News &amp; Media<\/a><\/em><\/p>","protected":false},"excerpt":{"rendered":"<p>May 23, 2023, the Provincial Center for ADR Monitoring and the Provincial Medical Products Administration visited Zhaoke Pharmaceutical (Hefei) Company Limited (&#8220;Zhaoke Hefei&#8221;), a subsidiary of Lee\u2019s Pharmaceutical Holdings Limited (\u201cLee\u2019s Pharm\u201d or \u201cthe Group\u201d, HKEx:00950), to conduct on-site assessment. More than 10 pharmaceutical enterprises in Hefei were also invited, including representative enterprises which manufacture [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1254,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[32,29],"tags":[],"class_list":["post-1253","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-lees-pharm-group-news","category-news"],"_links":{"self":[{"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/posts\/1253","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/comments?post=1253"}],"version-history":[{"count":1,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/posts\/1253\/revisions"}],"predecessor-version":[{"id":1255,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/posts\/1253\/revisions\/1255"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/media\/1254"}],"wp:attachment":[{"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/media?parent=1253"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/categories?post=1253"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lee-pharm.com\/en\/wp-json\/wp\/v2\/tags?post=1253"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}